• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Simulations Plus, Inc. (Amendment)

    1/10/22 4:11:57 PM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email
    SC 13G/A 1 slpa1_11022.htm CONESTOGA CAPITAL ADVISORS slpa1_11022.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
    Simulations Plus
    (Name of Issuer)
    Common Stock, $0.01 Par Value
    (Title of Class of Securities)
    829214105
    (CUSIP Number)
    December 31, 2021
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [X] Rule 13d-1(b)
    [   ] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 829214105
           
    1
    NAME OF REPORTING PERSON
    Conestoga Capital Advisors LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    23-3072906
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    2,223,168
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    2,327,187
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    2,327,187
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    11.55%
    12
    TYPE OF REPORTING PERSON
    IA
    CUSIP No.: 829214105
           
    1
    NAME OF REPORTING PERSON
    Conestoga Small Cap Fund
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    22-3865089
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    1,533,596
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,533,596
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,533,596
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    7.61%
    12
    TYPE OF REPORTING PERSON
    IV
    CUSIP No.: 829214105
    ITEM 1(a). NAME OF ISSUER:
    Simulations Plus
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    42505 10th Street West
    Lancaster, CA 93534-7059
    ITEM 2(a). NAME OF PERSON FILING:
    Conestoga Capital Advisors LLC
    Conestoga Small Cap Fund
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    550 E. Swedesford Rd. Ste 120
    Wayne, PA 19087
    ITEM 2(c). CITIZENSHIP:
    Delaware
    Delaware
    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Common Stock, $0.01 Par Value
    ITEM 2(e). CUSIP NUMBER:
    829214105
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [X]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [X]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ ]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    As of December 31, 2021, the Reporting Persons Conestoga Capital Advisors indirectly beneficially owned 2,327,187 shares while the Conestoga Small Cap Fund owned 1,533,596 of the 20,147,714 of the Issuers Common Stock indirectly beneficially owned by Conestoga Capital Advisors. Such shares of the Issuers Common Stock were directly beneficially owned by the Accounts. The Conestoga Small Cap Fund beneficially owned 7.61% of the Issuers issued and outstanding Common Stock.
    (b) Percent of class:
    As of December 31, 2021, the Reporting Persons indirectly beneficially owned 11.55% in total with the Conestoga Small Cap Fund owning 7.61% of the Issuers issued and outstanding Common Stock (based on 20,147,714 shares of the Issuers Common Stock outstanding as of October 25, 2021 as reported by the Issuer in its Form 10-K filed on October 27, 2021.
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    Conestoga Capital Advisors LLC : 2,223,168
    Conestoga Small Cap Fund : 1,533,596
    (ii) shared power to vote or to direct the vote:
    Conestoga Capital Advisors LLC : 0
    Conestoga Small Cap Fund : 0
    (iii) sole power to dispose or direct the disposition of:
    Conestoga Capital Advisors LLC : 2,327,187
    Conestoga Small Cap Fund : 1,533,596
    (iv) shared power to dispose or to direct the disposition of:
    Conestoga Capital Advisors LLC : 0
    Conestoga Small Cap Fund : 0
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    CUSIP No.: 829214105
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    January 10 2022
    Conestoga Capital Advisors LLC
    By:
    /s/ Duane R. D'Orazio
    Name:
    Duane R. D'Orazio
    Title:
    Chief Compliance Officer
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    Get the next $SLP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    10/26/2021$65.00 → $53.00Hold → Buy
    Craig Hallum
    7/13/2021$95.00 → $54.00Outperform
    Raymond James
    More analyst ratings

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woltosz Walter S sold $366,623 worth of shares (20,000 units at $18.33), decreasing direct ownership by 0.60% to 3,304,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      7/2/25 4:24:37 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S sold $543,074 worth of shares (20,000 units at $27.15), decreasing direct ownership by 0.60% to 3,324,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      6/3/25 4:57:16 PM ET
      $SLP
      EDP Services
      Technology
    • Director Woltosz Walter S was granted 786 shares and sold $670,150 worth of shares (20,000 units at $33.51), decreasing direct ownership by 0.57% to 3,344,157 units (SEC Form 4)

      4 - Simulations Plus, Inc. (0001023459) (Issuer)

      5/1/25 5:53:05 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Simulations Plus Inc.

      10-Q - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 8:02:18 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/15/25 7:56:13 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Simulations Plus, Inc. (0001023459) (Filer)

      7/14/25 4:49:27 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Simulations Plus downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

      7/15/25 8:39:07 AM ET
      $SLP
      EDP Services
      Technology
    • Stephens initiated coverage on Simulations Plus with a new price target

      Stephens initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $39.00

      11/15/24 8:20:56 AM ET
      $SLP
      EDP Services
      Technology
    • KeyBanc Capital Markets initiated coverage on Simulations Plus with a new price target

      KeyBanc Capital Markets initiated coverage of Simulations Plus with a rating of Overweight and set a new price target of $47.00

      7/29/24 7:43:47 AM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    See more
    • QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

      QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

      6/12/24 8:58:00 AM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

      LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

      12/1/20 4:05:00 PM ET
      $DIS
      $SLP
      $F
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
      EDP Services
      Technology

    $SLP
    Financials

    Live finance-specific insights

    See more
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

      Updates fiscal 2025 revenue guidance range Third quarter fiscal 2025 full results to be released on July 2, 2025, with conference call at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue guidance. The Company expects to report third quarter fiscal 2025 revenue in the range of between $19 million and $20 million Full year fiscal 2025 revenue is expected to range between $76 millio

      6/11/25 4:30:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

      Total revenue grew 23% year-over-year driven by strong growth in both software and services Maintains full-year revenue guidance of $90 to $93 million and adjusted diluted EPS of $1.07 to $1.20 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its second quarter fiscal 2025, ended February 28, 2025. Second Quarter 2025 Financial Highlights (as compared to second quarter 2024) Total revenue increased 23% to $22.4 million Software revenue increased 16% to $13.5 million, repres

      4/3/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      8/8/24 2:18:03 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/13/24 5:13:58 PM ET
      $SLP
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

      SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

      2/12/24 4:59:04 PM ET
      $SLP
      EDP Services
      Technology

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Simulations Plus Invests in Clinical Development Technology Company Nurocor

      Investment to accelerate innovations in biopharma development through Corporate Development Initiative Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to improve efficiency, reusability, governance, and automation for pharmaceutical companies through digitalization in the clinical development phase. Its solution significantly accelerates the typical clinical trial lif

      7/14/25 4:15:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

      Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its third quarter fiscal 2025, ended May 31, 2025. Third Quarter 2025 Financial Highlights (as compared to third quarter 2024) Total revenue increased 10% to $20.4 million Software revenue increased 6% to $12.6 million, representing 62% of total revenue Services revenue increased 17% to $7.7 millio

      7/14/25 4:05:00 PM ET
      $SLP
      EDP Services
      Technology
    • Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

      Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O'Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices and Healthcare Services Forum taking place in Boston, Massachusetts. Mr. O'Connor will host one-on-one meetings with institutional investors on Tuesday, June 17, 2025. For more information about the events or questions about registration, interested parties should reach out to their contacts at Citizens. About Simulations Plus, Inc. With more

      6/12/25 7:50:00 AM ET
      $SLP
      EDP Services
      Technology